AquaBounty Technologies is a biotechnology company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish.[2] It aims to create products that aim to increase the productivity of aquaculture.[3] As of 2020, sale of salmon has been approved in Canada and the United States.
The underlying genetic technology that accelerates the growth and reduces the time to market for the AquAdvantage salmon was developed in 1989 at Memorial University in Newfoundland, Canada. In 2003, the first regulatory study of the fish was submitted in the U.S. to the Food and Drug Administration (FDA), who ruled that the fish were safe to eat and posed no threat to the environment when farmed in land-based aquaculture farms. In 2012, a submission was made to Health Canada to allow the sale of the genetically modified fish in Canada and the application was subsequently approved.[4] AquAdvantage salmon received FDA approval in 2015 and the first U.S. harvest of salmon occurred in 2020 at their Indiana-located aquafarm. As of 2022, a production facility is in construction in Ohio.[5]
Productsedit
The company has developed hybrid salmon, trout, and tilapia designed to grow faster than traditional fish. Only the salmon has progressed to government (Canada, United States) approvals[6] and are the first genetically modified animals approved for consumption.[7] Their hybrid Atlantic salmon incorporates a gene from a Chinook salmon, which bears a single copy of the stably integrated α-form of the opAFP-GHc2 gene construct at the α-locus in the EO-1α line (Ocean Pout AKA Eel).[8] AquaBounty has patented and trademarked this fish as the AquAdvantage salmon, a sterile Atlantic salmon female that can grow to market size in half the time of conventional salmon.[9]
The company was reported to have made its first sale of 4.5 metric tons (4.4 long tons; 5.0 short tons) of AquaAdvantage salmon to Canadian customers in July 2017.[10] Sales in the U.S. started May 2021.[11]
Financesedit
In 2012, a New York Times article reported the finances of AquaBounty were not in good shape and the company had to reduce staff from 27 to 12.[12] In March 2012, AquaBounty raised US$2 million in new capital, but this would only last until the end of the year.[12] Georgian investor Kakha Bendukidze owned 47.6% of the company's stock before selling to American synthetic biology firm Intrexon in October 2012. Intrexon put up $500,000 in bridge financing and offered to buy the rest of the company.[9][13] Intrexon acquired majority ownership of Aquabounty in 2013.[14] In 2019 Intrexon sold Aquabounty - which continues as a publicly held company - to TS Aquaculture, LLC, a privately held company managed by Third Security, LLC, a venture capital firm led by former Intrexon Chairman & CEO Randal J. Kirk.[15]
Referencesedit
^ ab. Archived from the original on 2011-06-28. Retrieved 2011-03-18.
^"Canada Approves Sale of Genetically Modified Salmon". Democracy Now!.
^. Bloomberg Businessweek. Archived from the original on 2012-10-11. Retrieved 2011-03-18.
^Canada, Health (2016-05-19). "AquAdvantage Salmon". aem. Retrieved 2021-01-12.
^Chesto, Jon (March 24, 2019). "AquaBounty's genetically engineered fish swim closer to sales in US". Boston Globe. Retrieved 25 March 2019.
^"Like salmon? They're now the first genetically modified animals approved for consumption". USA TODAY. Retrieved 2021-01-11.
^Staveley, Jane P. (25 August 2010). (PDF). Food and Drug Administration. Archived from the original (PDF) on 26 September 2012. Retrieved 2012-10-03.
^ abPollack, Andrew (December 21, 2012). "Engineered Fish Moves a Step Closer to Approval". The New York Times.
^Waltz,Nature, Emily. "First Genetically Engineered Salmon Sold in Canada". Scientific American. Retrieved 2017-08-08.
^Smith, Casey (21 May 2021). "Genetically modified salmon head to US dinner plates". AP News. Retrieved 6 August 2021.
^ abPollack, Andrew (21 May 2012) An Entrepreneur Bankrolls a Genetically Engineered Salmon. The New York Times, Retrieved 3 October 2012
^. Fishupdate.com. December 10, 2012. Archived from the original on January 21, 2013.
^Jacob Bunge (15 December 2015) Firm Bets on Biotech That Changes How Food Is Produced. The Wall Street Journal, retrieved 30 January 2016
^House, Douglas G (31 October 2019). "Intrexon sells AquaBounty stake to CEO-affiliated aquaculture business". Seeking Alpha. Retrieved 2 December 2020.
External linksedit
Official website
This fishing-related article is a stub. You can help Wikipedia by expanding it.
aquabounty, technologies, biotechnology, company, based, maynard, massachusetts, united, states, company, notable, research, development, genetically, modified, fish, aims, create, products, that, increase, productivity, aquaculture, 2020, sale, salmon, been, . AquaBounty Technologies is a biotechnology company based in Maynard Massachusetts United States The company is notable for its research and development of genetically modified fish 2 It aims to create products that aim to increase the productivity of aquaculture 3 As of 2020 sale of salmon has been approved in Canada and the United States AquaBounty Technologies Inc Traded asNasdaq AQBRussell Microcap Index componentIndustryBiotechnologyAquacultureFounded1991 1 HeadquartersMaynard Massachusetts 1 Key peopleSylvia Wulf President amp CEO ParentTS Aquaculture LLCWebsiteaquabounty wbr com Contents 1 History 2 Products 3 Finances 4 References 5 External linksHistory editThe underlying genetic technology that accelerates the growth and reduces the time to market for the AquAdvantage salmon was developed in 1989 at Memorial University in Newfoundland Canada In 2003 the first regulatory study of the fish was submitted in the U S to the Food and Drug Administration FDA who ruled that the fish were safe to eat and posed no threat to the environment when farmed in land based aquaculture farms In 2012 a submission was made to Health Canada to allow the sale of the genetically modified fish in Canada and the application was subsequently approved 4 AquAdvantage salmon received FDA approval in 2015 and the first U S harvest of salmon occurred in 2020 at their Indiana located aquafarm As of 2022 a production facility is in construction in Ohio 5 Products editThe company has developed hybrid salmon trout and tilapia designed to grow faster than traditional fish Only the salmon has progressed to government Canada United States approvals 6 and are the first genetically modified animals approved for consumption 7 Their hybrid Atlantic salmon incorporates a gene from a Chinook salmon which bears a single copy of the stably integrated a form of the opAFP GHc2 gene construct at the a locus in the EO 1a line Ocean Pout AKA Eel 8 AquaBounty has patented and trademarked this fish as the AquAdvantage salmon a sterile Atlantic salmon female that can grow to market size in half the time of conventional salmon 9 The company was reported to have made its first sale of 4 5 metric tons 4 4 long tons 5 0 short tons of AquaAdvantage salmon to Canadian customers in July 2017 10 Sales in the U S started May 2021 11 Finances editIn 2012 a New York Times article reported the finances of AquaBounty were not in good shape and the company had to reduce staff from 27 to 12 12 In March 2012 AquaBounty raised US 2 million in new capital but this would only last until the end of the year 12 Georgian investor Kakha Bendukidze owned 47 6 of the company s stock before selling to American synthetic biology firm Intrexon in October 2012 Intrexon put up 500 000 in bridge financing and offered to buy the rest of the company 9 13 Intrexon acquired majority ownership of Aquabounty in 2013 14 In 2019 Intrexon sold Aquabounty which continues as a publicly held company to TS Aquaculture LLC a privately held company managed by Third Security LLC a venture capital firm led by former Intrexon Chairman amp CEO Randal J Kirk 15 References edit a b Company amp History Archived from the original on 2011 06 28 Retrieved 2011 03 18 Canada Approves Sale of Genetically Modified Salmon Democracy Now AquaBounty Technologies Company Overview Bloomberg Businessweek Archived from the original on 2012 10 11 Retrieved 2011 03 18 Canada Health 2016 05 19 AquAdvantage Salmon aem Retrieved 2021 01 12 About Us aquabounty com Retrieved 2022 06 08 Chesto Jon March 24 2019 AquaBounty s genetically engineered fish swim closer to sales in US Boston Globe Retrieved 25 March 2019 Like salmon They re now the first genetically modified animals approved for consumption USA TODAY Retrieved 2021 01 11 Staveley Jane P 25 August 2010 Environmental Assessment for AquAdvantage Salmon PDF Food and Drug Administration Archived from the original PDF on 26 September 2012 Retrieved 2012 10 03 a b Pollack Andrew December 21 2012 Engineered Fish Moves a Step Closer to Approval The New York Times Waltz Nature Emily First Genetically Engineered Salmon Sold in Canada Scientific American Retrieved 2017 08 08 Smith Casey 21 May 2021 Genetically modified salmon head to US dinner plates AP News Retrieved 6 August 2021 a b Pollack Andrew 21 May 2012 An Entrepreneur Bankrolls a Genetically Engineered Salmon The New York Times Retrieved 3 October 2012 Delays put question mark over GM salmon as development company receives bid Fishupdate com December 10 2012 Archived from the original on January 21 2013 Jacob Bunge 15 December 2015 Firm Bets on Biotech That Changes How Food Is Produced The Wall Street Journal retrieved 30 January 2016 House Douglas G 31 October 2019 Intrexon sells AquaBounty stake to CEO affiliated aquaculture business Seeking Alpha Retrieved 2 December 2020 External links editOfficial website nbsp This fishing related article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title AquaBounty Technologies amp oldid 1146438689, wikipedia, wiki, book, books, library,
